Stocks staged a Fed-day post St. Patty's Day hungover tantrum Wednesday, as investors discovered that “higher for longer” still means exactly what it sounds like.
Indexes and Rates
The Dow industrials fell sharply, at one point flirting with a 700‑plus point slide,…
The Federal Reserve’s latest rate decision landed not with a bang, but with the kind of carefully measured thud Wall Street has come to admire: steady, data-dependent, and just hawkish enough to keep the bond vigilantes awake.
Fed Holds the Line as…
Wall Street spent St. Patrick’s Day edging back into the green, as investors raised a cautious toast to the Federal Reserve and NVIDIA’s AI ambitions rather than to rapid-fire rate cuts.
Indices and macro mood
US stocks advanced for a second straight…
Wall Street opened the week in an oddly good mood, as if the market decided that worrying about everything, all at once, was bad for performance. Stocks climbed on Monday while oil prices eased, even as President Trump publicly prodded U.S. allies…
In an AI market obsessed with GPUs and stardust, Nokia (NOK) is quietly reminding investors that none of this magic moves without serious plumbing. While Nvidia (NVDA) prepares to headline its GTC 2026 “Woodstock of AI” showcase, the chip giant has already…
US stocks notched a third straight week of losses into Friday, March 13, 2026, as oil’s lunge toward 100100 a barrel reignited inflation jitters, pushed out Fed rate‑cut hopes, and kept investors firmly in risk‑off mode.
Indexes: Red Week, Oil-Driven
The Dow, S&P 500,…
US stocks extended their slide Thursday as oil’s renewed march toward triple digits collided with war and credit worries to knock major indexes sharply lower.
Indexes: Risk-Off Takes the Wheel
The Dow Jones Industrial Average dropped roughly 739 points, or around 1.56%,…
US stocks extended their pullback on Wednesday, March 11, 2026, as investors grappled with fresh inflation data, surging oil prices, and ongoing fallout from the Iran war.
Indexes and overall tone
The Dow Jones Industrial Average fell close to .61%, adding to…
Vertiv’s (VRT) latest move reads like a front‑page Wall Street story for the AI era: a power-and-cooling heavyweight teaming with a deep‑pocketed infrastructure investor to keep NVIDIA‑class data centers humming in markets where the grid is already wheezing.
Vertiv, Generate Capital and…
French pharmaceutical group Servier has quietly become one of the most methodical players in oncology—and its latest move underscores that reputation. The company announced a definitive agreement to acquire Day One Biopharmaceuticals (Nasdaq: DAWN) for $21.50 per share in cash, valuing the…
